Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
Gillina F. G. Bezemer, Johan Garssen
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Moumita Manik, Rakesh Kumar Singh
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 869-877
Open Access | Times Cited: 132
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage
Tiago J. Costa, Simone R. Potje, Thais Fernanda de Campos Fraga‐Silva, et al.
Vascular Pharmacology (2021) Vol. 142, pp. 106946-106946
Open Access | Times Cited: 93
Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases
Xidian Tang, Tiantian Ji, Jia-Rui Dong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13009-13009
Open Access | Times Cited: 70
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 68
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
Zhimei Liu, Minghui Yang, Kun Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll‐like receptors dictates pathophysiology of COVID‐19 disease
Mohammad Kazem Vakil, Yaser Mansoori, Ghaidaa Raheem Lateef Al‐Awsi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4088-4096
Open Access | Times Cited: 30
TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
A synbiotic mixture of Bifidobacterium breve M16-V, oligosaccharides and pectin, enhances Short Chain Fatty Acid production and improves lung health in a preclinical model for pulmonary neutrophilia
Gillina F. G. Bezemer, Mara A. P. Diks, Esmaeil Mortaz, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 5
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
Hi Eun Jung, Heung Kyu Lee
Viruses (2021) Vol. 13, Iss. 11, pp. 2132-2132
Open Access | Times Cited: 39
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors
Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8010-8041
Closed Access | Times Cited: 35
TLR9: A friend or a foe
Mona M. Saber, Nada Monir, Azza S. Awad, et al.
Life Sciences (2022) Vol. 307, pp. 120874-120874
Closed Access | Times Cited: 24
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
Jason Girkin, Steven Maltby, Nathan W. Bartlett
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210274-210274
Open Access | Times Cited: 23
Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis
Alshaymaa M. Alhabibi, Asmaa S. Hassan, Nashwa Mohamed Abd Elbaky, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 665-675
Open Access | Times Cited: 14
Activation of innate immune receptor TLR9 by mitochondrial DNA plays essential roles in the chemical long-term depression of hippocampal neurons
Naoya Atarashi, Misaki Morishita, Shinji Matsuda
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105744-105744
Open Access | Times Cited: 4
Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients
María José Docampo, Mattei Batruch, Pietro Oldrati, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 4
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 21
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease – 3rd CIAO AOP Design Workshop
Laure‐Alix Clerbaux
ALTEX (2022)
Open Access | Times Cited: 18
Nutritional Impact and Its Potential Consequences on COVID-19 Severity
Esmaeil Mortaz, Gillina F. G. Bezemer, Shamila D. Alipoor, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 23
Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond
Volodymyr V. Oberemok, Oksana A. Andreeva, Kateryna V. Laikova, et al.
Inflammation Research (2022) Vol. 71, Iss. 7-8, pp. 729-739
Open Access | Times Cited: 17
Effects of aging and lifelong aerobic exercise on expression of innate immune components in skeletal muscle of women
Ryan K. Perkins, Kaleen M. Lavin, Ulrika Raue, et al.
Journal of Applied Physiology (2024) Vol. 136, Iss. 3, pp. 482-491
Closed Access | Times Cited: 2
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
Ali Salimi Jeda, Sina Abbassi, Atieh Mousavizadeh, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108232-108232
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top